HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Flash-evoked afterdischarge in rat as a model of the absence seizure: dose-response studies with therapeutic drugs.

Abstract
The flash-evoked afterdischarge (FEAD) is a self-sustained burst of wave-and-spike complexes recorded from occipital cortex in the rat and other animals in response to a single light flash. On the basis of behavioral experiments and studies employing single doses of antiepileptic drugs, FEAD has been proposed as a model of the absence seizure. In order to test the validity of FEAD as an absence seizure model, the present experiments determined dose-response relationships for the suppression of FEAD by six antiepileptic drugs with established clinical profiles. It was found that phenobarbital, ethosuximide, and trimethadione suppressed FEAD in a dose-related manner, and that ethosuximide was approximately three times as potent as trimethadione. Mephenytoin produced a maximal reduction of FEAD of only 30 to 40%, which was not dose-related. Neither phenytoin nor acetazolamide suppressed FEAD. The results obtained with ethosuximide, trimethadione, and phenytoin are qualitatively similar to their therapeutic effects in absence epilepsy. The FEAD model failed, however, to unequivocally predict the therapeutic efficacy of mephenytoin or acetazolamide. In this respect, it is similar to the metrazol seizure model. It is concluded that FEAD is a valid absence seizure model with a pharmacological predictive value that is at least as good as the metrazol model.
AuthorsG A King, W M Burnham, K E Livingston
JournalEpilepsia (Epilepsia) Vol. 21 Issue 5 Pg. 531-9 (Oct 1980) ISSN: 0013-9580 [Print] UNITED STATES
PMID7418668 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ethosuximide
  • Phenytoin
  • Acetazolamide
  • Mephenytoin
  • Trimethadione
  • Phenobarbital
Topics
  • Acetazolamide (therapeutic use)
  • Animals
  • Dose-Response Relationship, Drug
  • Ethosuximide (therapeutic use)
  • Evoked Potentials (drug effects)
  • Male
  • Mephenytoin (therapeutic use)
  • Phenobarbital (therapeutic use)
  • Phenytoin (therapeutic use)
  • Photic Stimulation
  • Rats
  • Seizures (drug therapy)
  • Trimethadione (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD